Lymphocytic Leukemia, Chronic Clinical Trials

A listing of Lymphocytic Leukemia, Chronic medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 332 clinical trials
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199) With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL

compared to chemoimmunotherapy in subjects with previously untreated CLL.

acp-196
rituximab
obinutuzumab
fludarabine
bendamustine
  • 344 views
  • 20 Sep, 2021
  • 246 locations
Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients

This is a global, Phase 3b, multicenter, open-label, single-arm study to evaluate the safety and efficacy of acalabrutinib 100 mg bid in approximately 600 participants with chronic lymphocytic

TP53
acalabrutinib
tyrosine
recurrent chronic lymphocytic leukemia
lymphocytosis
  • 282 views
  • 31 Aug, 2021
  • 160 locations
Study to Assess the Efficacy and Safety of Ublituximab in Combination With Umbralisib and Venetoclax Compared to Ublituximab in Combination With Umbralisib in Subjects With CLL (ULTRA-V)

with Chronic Lymphocytic Leukemia (CLL)

chronic lymphocytic leukemia
lymphoid leukemia
venetoclax
monoclonal antibodies
monoclonal protein
  • 21 views
  • 23 Sep, 2021
  • 43 locations
  • 1 views
  • 30 Mar, 2021
  • 1 location
Safety Efficacy of BNT162b2 mRNA Vaccine in CLL

On behalf of the Israel CLL study group the investigators will evaluate the efficacy and safety of BNT162b2 mRNA Covid-19 Vaccine in patients with chronic lymphocytic leukemia

chronic lymphocytic leukemia
  • 0 views
  • 22 Sep, 2021
  • 2 locations
Double-blind Randomized Placebo-controlled Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients with Chronic Lymphocytic Leukemia

igiv
primary infection
chronic lymphocytic leukemia
  • 0 views
  • 12 Sep, 2021
  • 38 locations
Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With CLL or SLL

This is a study for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) who have previously received treatment with at least a BTK inhibitor. The main purpose is

rituximab
btk inhibitor
neutrophil count
bendamustine
chronic lymphocytic leukemia
  • 2 views
  • 23 Sep, 2021
  • 111 locations
Muscle Stimulation for Physical Function During Stem Cell Transplant

Some blood, bone marrow, and lymphatic (hematologic) cancers such as Hodgkin/Non-Hodgkin lymphomas, chronic lymphocytic leukemia, and multiple myeloma, are over-represented in Veterans due to

  • 0 views
  • 31 May, 2021
  • 1 location
A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

lymphoma (NHL) and chronic lymphocytic leukemia (CLL) (Part A - Dose Escalation); and the safety of the RP2Ds for this combination in different histologies/participant populations (Part B - Cohort

leukemia
lymphoma
chronic lymphocytic leukemia
  • 0 views
  • 16 Sep, 2021
  • 33 locations
CD19-specific CAR-T Cells in CLL/SLL and DLBCL

(CAR) and manufactured with a new process. CAR-T cells will be investigated in combination with ibrutinib in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and as single agent in

  • 22 views
  • 07 Jul, 2021
  • 18 locations